How have TRIB shares performed in 2023?

Trinity Biotech's stock was trading at $0.99 at the beginning of the year. Since then, TRIB stock has decreased by 44.4% and is now trading at $0.55. View the best growth stocks for 2023 here .

Are investors shorting Trinity Biotech?

Trinity Biotech saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 59,700 shares, an increase of 70.1% from the October 31st total of 35,100 shares. Based on an average trading volume of 27,600 shares, the short-interest ratio is presently 2.2 days. View Trinity Biotech's Short Interest .

How were Trinity Biotech's earnings last quarter?

Trinity Biotech plc (NASDAQ:TRIB) released its earnings results on Tuesday, October, 3rd. The company reported ($0.20) EPS for the quarter. The business earned $13.90 million during the quarter. Trinity Biotech had a negative trailing twelve-month return on equity of 870.11% and a negative net margin of 46.51%.

What guidance has Trinity Biotech issued on next quarter's earnings?

Trinity Biotech issued an update on its third quarter 2023 earnings guidance on Tuesday, October, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.00 million-$15.00 million, compared to the consensus revenue estimate of $15.00 million.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?

20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com . Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Trinity Biotech own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD) , Novavax (NVAX) , OPKO Health (OPK) , Sorrento Therapeutics (SRNE) , Advanced Micro Devices (AMD) , Netflix (NFLX) , Pfizer (PFE) , QUALCOMM (QCOM) , Energy Transfer (ET) and Exxon Mobil (XOM) .

Who are Trinity Biotech's major shareholders?

Trinity Biotech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%).

How do I buy shares of Trinity Biotech?

Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull , Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here .

Trinity Biotech Stock Price, News & Analysis (NASDAQ:TRIB)

$0.55

+0.04 (+7.84%)

(As of 12/8/2023 ET)

Compare

Today's Range: $0.50
▼
$0.55
50-Day Range: $0.39
▼
$0.74
52-Week Range: $0.37
▼
$1.29

Volume: 38,204 shs
Average Volume: 47,870 shs
Market Capitalization: $20.96 million

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: N/A

About Trinity Biotech Stock (NASDAQ:TRIB)

Trinity Biotech plc acquires, together with its subsidiaries, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious diseases, such as lyme disease; sexually transmitted diseases consisting syphilis and herpes; SARS-CoV-2; and epstein barr, measles, mumps, toxoplasmosis, cytomegalovirus, rubella, varicella and other viral pathogens, as well as products for the in-vitro diagnostic testing for haemoglobin A1c used in the monitoring and diagnosis of diabetes, and identifying those who are at a risk of developing diabetes. It also provides laboratory-testing services for Sjogren's syndrome, hearing loss, celiac disease, lupus, rheumatoid arthritis, systemic sclerosis, and other laboratory-testing services for autoimmune disorders. The company develops, manufactures, and sells products in the immunofluorescence assay, enzyme-linked immunosorbent, western blot, and line immunoassay formats; and provides reagent products, such as ACE, bile acids, lactate, oxalate, and glucose-6-phosphate dehydrogenase for diagnosis of liver and kidney diseases, as well as haemolytic anaemia. In addition, the company sells raw materials to the life sciences industry and research institutes. It serves public health authorities, non-governmental organisations, and clinical and reference laboratories through its direct sales force, as well as through a network of independent distributors and strategic partners. Trinity Biotech plc was incorporated in 1992 and is headquartered in Bray, Ireland.

TRIB Stock Price History

30 days | 90 days | 365 days | Advanced Chart

TRIB Stock News Headlines

December 2, 2023 | americanbankingnews.com

StockNews.com Initiates Coverage on Trinity Biotech (NASDAQ:TRIB)

November 28, 2023 | finance.yahoo.com

Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Global Select Requirement for Minimum Market Value of Publicly Held Shares

December 9, 2023 | DTI Trader (Ad)

New CBOE “special perk” helps traders target income every weekend

You might not immediately realize what you’re reading. Let me help you out a little… What you're looking at is a “special perk” set up by the Chicago Board of Options Exchange.

November 22, 2023 | msn.com

Oil Stocks Lead European Equities Traded in the US as American Depositary Receipts Lower in Wednesday Trading

November 6, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

November 3, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Trend Lower Friday; Set to End Week Up 2.5%

October 23, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Start Week Higher in Monday Trading

October 10, 2023 | finance.yahoo.com

Trinity Biotech Welcomes The Decision Of The High Court Of Kenya To Strike Out The Applications To Prevent the Procurement of TrinScreen HIV By The Kenyan Ministry of Health

December 9, 2023 | Autonomix (Ad)

How to Invest Early In the Next Potential Breakthrough Nerve-Sensing Technology

Autonomix is preparing a public listing as they develop technology to potentially detect and treat a range of nervous system disorders with much greater visibility than available today. Now, their management team sees a potentially untapped $100B market opportunity.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

October 5, 2023 | finance.yahoo.com

Trinity Biotech plc (NASDAQ:TRIB) Q2 2023 Earnings Call Transcript

October 5, 2023 | finance.yahoo.com

Trinity Biotech plc (NASDAQ:TRIB) Just Reported Earnings, And Analysts Cut Their Target Price

October 3, 2023 | finanznachrichten.de

Trinity Biotech plc: Trinity Biotech Announces Q2 2023 Financial Results

October 3, 2023 | finance.yahoo.com

Trinity Biotech Announces Q2 2023 Financial Results

September 28, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Trend Lower After Positive Start in Wednesday Trading

September 27, 2023 | finance.yahoo.com

Trinity Biotech plc to Announce Second Quarter Fiscal Year 2023 Financial Results

September 21, 2023 | msn.com

The biotech CEO trying to reverse aging has removed all but 3 things from his bedroom

September 12, 2023 | finanznachrichten.de

Trinity Biotech plc: Trinity Biotech Receives Non-Compliance Notice Regarding Nasdaq Minimum Bid Price Requirement

September 11, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Open Week Higher Monday

September 8, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Trend Modestly Higher Friday

September 1, 2023 | finance.yahoo.com

Should You Investigate Trinity Biotech plc (NASDAQ:TRIB) At US$0.80?

August 28, 2023 | finance.yahoo.com

Trinity Biotech PLC (TRIB): A Comprehensive Analysis of Its Market Value

August 25, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Decline Friday, Set to End Week 1% Lower

August 24, 2023 | msn.com

Pharmaceutical Stocks Lead European Equities Traded in the US as American Depositary Receipts Lower Thursday

August 18, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Trend Lower Friday

August 15, 2023 | benzinga.com

Trinity Packaging Supply Named to Inc. Magazine's Fastest-Growing Companies 2023

August 8, 2023 | msn.com

Pharma Stocks Lead European Equities Traded in the US as American Depositary Receipts Slightly Higher Tuesday

August 7, 2023 | msn.com

European Equities Traded in the US as American Depositary Receipts Kick Off Week on Strong Note

See More Headlines

Receive TRIB Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Trinity Biotech and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 10/03/2023
Today: 12/09/2023
Fiscal Year End: 12/31/2023

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Diagnostic substances
Sub-Industry: N/A
Sector: Medical
Current Symbol: NASDAQ:TRIB
CUSIP: N/A
CIK: 888721
Web: www.trinitybiotech.com
Phone: (531) 276-9800
Fax: 353-1276-9888
Employees: 398
Year Founded: 1992

Profitability

EPS (Most Recent Fiscal Year): ($0.81)
Trailing P/E Ratio: N/A
Forward P/E Ratio: N/A
P/E Growth: N/A
Net Income: $-41,010,000.00
Net Margins: -46.51%
Pretax Margin: -64.52%
Return on Equity: -870.11%
Return on Assets: -31.19%

Debt

Debt-to-Equity Ratio: N/A
Current Ratio: 3.59
Quick Ratio: 2.06

Sales & Book Value

Annual Sales: $72.42 million
Price / Sales: 0.29
Cash Flow: N/A
Price / Cash Flow: N/A
Book Value: ($0.06) per share
Price / Book: -9.17

Miscellaneous

Outstanding Shares: 38,108,000
Free Float: 34,983,000
Market Cap: $20.96 million
Optionable: Optionable
Beta: 1.41

Social Links

10 Best Cheap Stocks to Buy Now

MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.

Get This Free Report

Key Executives

Mr. Aris Kekedjian (Age 56)
CEO & Chairman
Comp: $387k
Mr. Ronan O'Caoimh (Age 67)
Founder & Director
Comp: $340k
Mr. John Gillard (Age 42)
CFO, Company Secretary & Executive Director
Comp: $863k
Dr. James Walsh Ph.D. (Age 65)
Executive Director of Business Development & Executive Director
Comp: $20k
Mr. Simon Dunne (Age 49)
Chief Accounting Officer
Dr. Gary Keating Ph.D. (Age 50)
Chief Technology Officer
Ms. Eibhlin Kelly (Age 39)
Chief Information Officer
Mr. Colm Molloy (Age 52)
Group Director of Human Resources & Culture

Key Competitors

View All Competitors

TRIB Stock Analysis - Frequently Asked Questions

How have TRIB shares performed in 2023?: Trinity Biotech's stock was trading at $0.99 at the beginning of the year. Since then, TRIB stock has decreased by 44.4% and is now trading at $0.55.
View the best growth stocks for 2023 here.
Are investors shorting Trinity Biotech?: Trinity Biotech saw a increase in short interest in the month of November. As of November 15th, there was short interest totaling 59,700 shares, an increase of 70.1% from the October 31st total of 35,100 shares. Based on an average trading volume of 27,600 shares, the short-interest ratio is presently 2.2 days.
View Trinity Biotech's Short Interest.
How were Trinity Biotech's earnings last quarter?: Trinity Biotech plc (NASDAQ:TRIB) released its earnings results on Tuesday, October, 3rd. The company reported ($0.20) EPS for the quarter. The business earned $13.90 million during the quarter. Trinity Biotech had a negative trailing twelve-month return on equity of 870.11% and a negative net margin of 46.51%.
What guidance has Trinity Biotech issued on next quarter's earnings?: Trinity Biotech issued an update on its third quarter 2023 earnings guidance on Tuesday, October, 3rd. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $14.00 million-$15.00 million, compared to the consensus revenue estimate of $15.00 million.

What is Ronan O'Caoimh's approval rating as Trinity Biotech's CEO?: 20 employees have rated Trinity Biotech Chief Executive Officer Ronan O'Caoimh on Glassdoor.com. Ronan O'Caoimh has an approval rating of 8% among the company's employees. This puts Ronan O'Caoimh in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Trinity Biotech own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Trinity Biotech investors own include Gilead Sciences (GILD), Novavax (NVAX), OPKO Health (OPK), Sorrento Therapeutics (SRNE), Advanced Micro Devices (AMD), Netflix (NFLX), Pfizer (PFE), QUALCOMM (QCOM), Energy Transfer (ET) and Exxon Mobil (XOM).
Who are Trinity Biotech's major shareholders?: Trinity Biotech's stock is owned by a number of retail and institutional investors. Top institutional shareholders include Group One Trading L.P. (0.00%) and Concourse Financial Group Securities Inc. (0.00%).
How do I buy shares of Trinity Biotech?: Shares of TRIB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

This page (NASDAQ:TRIB) was last updated on 12/9/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial